Literature DB >> 7540517

Adenovirus-mediated gene transfer in vivo to cerebral blood vessels and perivascular tissue.

H Ooboshi1, M J Welsh, C D Rios, B L Davidson, D D Heistad.   

Abstract

Gene transfer to blood vessels in vivo generally requires interruption of blood flow. Thus, gene transduction to cerebral blood vessels in vivo has not yet been achieved. In this study, we injected replication-deficient adenovirus into cerebrospinal fluid in an attempt to transduce genes to cerebral blood vessels. Recombinant adenovirus (1 x 10(9) infectious units) expressing nuclear-targeted bacterial beta-galactosidase driven by the cytomegalovirus promoter was injected into the cisterna magna of Sprague-Dawley rats. The brains were examined histochemically after staining with 5-bromo-4-chloro-3-indolyl-beta-D-galactopyranoside 1 to 7 days after injection of adenovirus. Leptomeningeal cells overlying the major arteries were efficiently transduced, and adventitial cells of large vessels and smooth muscle cells of small vessels were occasionally stained. beta-Galactosidase was expressed on days 1 and 3 after injection but was undetectable by day 7. Expression of the gene was 'targeted' by altering the position of the head. When viral suspension was injected while the rat was in a nose-down position, the reporter gene was expressed extensively on the ventral surface of the brain, especially along the circle of Willis. When the position was changed to the nose-up or lateral position, the inferior or lateral region of the brain was stained primarily. Administration of the virus into the lateral ventricle provided extensive expression in ependymal cells and leptomeninges with some transduction to cerebral blood vessels. Thus, adenovirus injected into cerebrospinal fluid provides gene transfer in vivo to cerebral blood vessels and, with greater efficiency, to perivascular tissue. Furthermore, cisternal delivery may target specific brain regions by positioning of the head.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7540517     DOI: 10.1161/01.res.77.1.7

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  9 in total

Review 1.  The future of gene therapy for stroke.

Authors:  C A Gunnett; D D Heistad
Journal:  Curr Hypertens Rep       Date:  2001-02       Impact factor: 5.369

2.  Novel methods for adenovirus-mediated gene transfer to blood vessels in vivo.

Authors:  H Ooboshi; C D Ríos; D D Heistad
Journal:  Mol Cell Biochem       Date:  1997-07       Impact factor: 3.396

Review 3.  Gene transfer to the vasculature: historical perspective and implication for future research objectives.

Authors:  Sarah J George; Andrew H Baker
Journal:  Mol Biotechnol       Date:  2002-10       Impact factor: 2.695

Review 4.  Gene transfer for cerebrovascular disease.

Authors:  V G Khurana; Z S Katusic
Journal:  Curr Cardiol Rep       Date:  2001-01       Impact factor: 2.931

5.  Effects of in vivo adventitial expression of recombinant endothelial nitric oxide synthase gene in cerebral arteries.

Authors:  A F Chen; S W Jiang; T B Crotty; M Tsutsui; L A Smith; T O'Brien; Z S Katusic
Journal:  Proc Natl Acad Sci U S A       Date:  1997-11-11       Impact factor: 11.205

6.  High-resolution 3D demonstration of regional heterogeneity in the glymphatic system.

Authors:  Xu-Zhong He; Xin Li; Zhen-Hua Li; Jing-Cai Meng; Rui-Ting Mao; Xue-Ke Zhang; Rong-Ting Zhang; Huai-Liang Huang; Qian Gui; Guang-Yin Xu; Lin-Hui Wang
Journal:  J Cereb Blood Flow Metab       Date:  2022-07-03       Impact factor: 6.960

7.  Age-related neuronal vulnerability to brain ischemia: A potential target of gene therapy.

Authors:  H Ooboshi; S Ibayashi; H Yao; J Takada; D D Heistad; M Fujishima
Journal:  J Am Aging Assoc       Date:  2001-01

Review 8.  Gene therapy for cerebral vascular disease: update 2003.

Authors:  Kazunori Toyoda; Yi Chu; Donald D Heistad
Journal:  Br J Pharmacol       Date:  2003-05       Impact factor: 8.739

Review 9.  Gene therapy for stroke: 2006 overview.

Authors:  Yi Chu; Jordan D Miller; Donald D Heistad
Journal:  Curr Hypertens Rep       Date:  2007-03       Impact factor: 4.592

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.